Telomere length in myelodysplastic syndromes

被引:45
|
作者
Rollison, Dana E. [1 ]
Epling-Burnette, P. K. [2 ]
Park, Jong Y. [1 ]
Lee, Ji-Hyun [1 ]
Park, Hyun [1 ]
Jonathan, Kristen [1 ]
Cole, Ashley L. [1 ]
Painter, Jeffrey S. [2 ]
Guerrier, Mayenha [2 ]
Melendez-Santiago, Johana [3 ]
Fulp, William [1 ]
Komrokji, Rami [4 ]
Lancet, Jeffrey [4 ]
List, Alan F. [4 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Program Immunol, Tampa, FL 33682 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Flow Cytometry Core Facil, Tampa, FL 33682 USA
[4] Univ S Florida, H Lee Moffitt Canc Ctr, Malignant Hematol Program, Tampa, FL 33682 USA
关键词
Myelodysplastic syndromes; telomere length; hTERT; WORLD-HEALTH-ORGANIZATION; CANCER RISK; MUTATIONS; GENE; CLASSIFICATION; ASSOCIATION; EXPOSURE; COHORT; BLOOD; CELLS;
D O I
10.3109/10428194.2011.568648
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between telomere length (TL) and predisposition to myelodysplastic syndromes (MDS) remains unclear. We compared peripheral blood leukocyte (PBL) TL among cases of histologically confirmed MDS (n = 65) who were treatment-naive with no prior cancer history to age-matched controls (n = 63). Relative TL was measured in PBLs and saliva by quantitative polymerase chain reaction (PCR) and in CD15+ and CD19+ cells by flow cytometry-fluorescence in situ hybridization (flow-FISH). Human telomerase reverse transcriptase gene (hTERT) mutations were assessed by PCR. After adjustment for age and sex, relative TLs were reduced in PBLs (p = 0.02), CD15+ (p = 0.01), CD19+ (p = 0.25), and saliva (p = 0.13) in MDS cases versus controls, although only the PBL and CD15+ results were statistically significant. Among MDS cases, CD15+ and CD19+ cell TLs were positively correlated (p = 0.03). PBL TL was reduced among those occupationally exposed to paints and pesticides, but was not associated with hTERT genotype. Future studies are needed to further investigate constitutional telomere attrition as a possible predisposing factor for MDS.
引用
收藏
页码:1528 / 1536
页数:9
相关论文
共 50 条
  • [41] Transfusions in myelodysplastic syndromes
    Rose, C.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2017, 24 (03) : 209 - 215
  • [42] Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
    Hwang, Sang Mee
    Kim, Seon Young
    Kim, Jung Ah
    Park, Hee-Sue
    Park, Si Nae
    Im, Kyongok
    Kim, Kwantae
    Kim, Sung-Min
    Lee, Dong Soon
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [43] Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
    Sang Mee Hwang
    Seon Young Kim
    Jung Ah Kim
    Hee-Sue Park
    Si Nae Park
    Kyongok Im
    Kwantae Kim
    Sung-Min Kim
    Dong Soon Lee
    Journal of Hematology & Oncology, 9
  • [44] An overview of myelodysplastic syndromes
    Pontrelli, Gina
    Loscalzo, Carina
    L'Eplattenier, Mark
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (06): : 17 - 21
  • [45] Epigenetics of myelodysplastic syndromes
    Itzykson, R.
    Fenaux, P.
    LEUKEMIA, 2014, 28 (03) : 497 - 506
  • [46] Metabolomics profiling reveals novel markers for leukocyte telomere length
    Zierer, Jonas
    Kastenmueller, Gabi
    Suhre, Karsten
    Gieger, Christian
    Codd, Veryan
    Tsai, Pei-Chien
    Bell, Jordana
    Peters, Annette
    Strauch, Konstantin
    Schulz, Holger
    Weidinger, Stephan
    Mohney, Robert P.
    Samani, Nilesh J.
    Spector, Tim
    Mangino, Massimo
    Menni, Cristina
    AGING-US, 2016, 8 (01): : 77 - 94
  • [47] Pediatric myelodysplastic syndromes
    Hofmann, Inga
    JOURNAL OF HEMATOPATHOLOGY, 2015, 8 (03) : 127 - 141
  • [48] The heritability of leucocyte telomere length dynamics
    Hjelmborg, Jacob B.
    Dalgard, Christine
    Moller, Soren
    Steenstrup, Troels
    Kimura, Masayuki
    Christensen, Kaare
    Kyvik, Kirsten O.
    Aviv, Abraham
    JOURNAL OF MEDICAL GENETICS, 2015, 52 (05) : 297 - 302
  • [49] Telomere length and cardiovascular disease risk
    Zhan, Yiqiang
    Hagg, Sara
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (03) : 270 - 274
  • [50] Treatment Considerations of Myelodysplastic Syndromes/ Neoplasms for Pathologists
    Madanat, Yazan F.
    Zeidan, Amer M.
    CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 685 - 698